View in EDS

Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status.

Saved in:
Bibliographic Details
Title: Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status.
Authors: Freeman CL; H. Lee Moffitt Cancer Centre and Research Institute, Tampa, FL.; Morsani College of Medicine, University of South Florida, Tampa, FL., Srinivasan S; Johnson & Johnson, Spring House, PA., Hodkinson B; Johnson & Johnson, Spring House, PA., Deshpande S; Johnson & Johnson, Raritan, NJ., Henninger T; Johnson & Johnson, Raritan, NJ., Boyle M; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada., Wang ML; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Dreyling M; Department of Medicine III, Ludwig Maximilian University Hospital, Munich, Germany., Scott DW; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Source: Blood [Blood] 2025 Jun 19; Vol. 145 (25), pp. 3052-3056.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40101138
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Freeman+CL%22">Freeman CL</searchLink>; H. Lee Moffitt Cancer Centre and Research Institute, Tampa, FL.; Morsani College of Medicine, University of South Florida, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Srinivasan+S%22">Srinivasan S</searchLink>; Johnson & Johnson, Spring House, PA.<br /><searchLink fieldCode="AU" term="%22Hodkinson+B%22">Hodkinson B</searchLink>; Johnson & Johnson, Spring House, PA.<br /><searchLink fieldCode="AU" term="%22Deshpande+S%22">Deshpande S</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Henninger+T%22">Henninger T</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Boyle+M%22">Boyle M</searchLink>; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Wang+ML%22">Wang ML</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Dreyling+M%22">Dreyling M</searchLink>; Department of Medicine III, Ludwig Maximilian University Hospital, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Scott+DW%22">Scott DW</searchLink>; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2025 Jun 19; Vol. 145 (25), pp. 3052-3056.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40101138
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2024026003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3052
    Titles:
      – TitleFull: Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Freeman CL
      – PersonEntity:
          Name:
            NameFull: Srinivasan S
      – PersonEntity:
          Name:
            NameFull: Hodkinson B
      – PersonEntity:
          Name:
            NameFull: Deshpande S
      – PersonEntity:
          Name:
            NameFull: Henninger T
      – PersonEntity:
          Name:
            NameFull: Boyle M
      – PersonEntity:
          Name:
            NameFull: Wang ML
      – PersonEntity:
          Name:
            NameFull: Dreyling M
      – PersonEntity:
          Name:
            NameFull: Scott DW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 06
              Text: 2025 Jun 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 145
            – Type: issue
              Value: 25
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1